Axsome Therapeutics (NASDAQ: AXSM) insider plans 49,670-share exercise-and-sell
Rhea-AI Filing Summary
Axsome Therapeutics filed a Form 144 reporting an intended sale of 49,670 shares of Common Stock. The shares were acquired on 03/15/2017 pursuant to stock options and the planned disposition is described as a cashless exercise / same-day sale. The filing lists 06/09/2026 as a related date.
Positive
- None.
Negative
- None.
Insights
Form 144 notice: an insider plans an exercise-and-sale of 49,670 shares acquired in 2017.
The filing shows 49,670 shares were acquired as compensation via stock options on 03/15/2017 and the proposed method is a cashless exercise / same-day sale. The Form 144 provides the regulatory notice required for sales by affiliates under Rule 144.
Timing and actual sale execution depend on broker/dealer processing and any Rule 144 volume or manner-of-sale limits; subsequent Form 4 or trade reports will show completion and proceeds.